Skip to main content

Phio Pharmaceuticals Corp.

PHIO
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
SEC CIK
0001533040

In the last 90 days, Phio Pharmaceuticals Corp. insiders filed 5 open-market purchases and 0 sales; 24 institutions reported holding it in 13F filings for Q2 2026, worth $662.6K in total; no superinvestor holds it.

Holders of 5% or more of PHIO

Holders whose latest Schedule 13D or 13G filing reports 5% or more of Phio Pharmaceuticals Corp., largest stake first. The change is against the holder's previous filing.

Holders of 5% or more of PHIO
HolderLatest formStakeChangeFirst filedLatest filingFiling
CVI Investments, Inc.13G9.90%733.3K shares+5.00 ppfrom 4.90%Dec 26, 20243 filingsNov 10, 2025SEC
Intracoastal Capital, LLC13G/A7.00%430.0K shares−2.99 ppfrom 9.99%Dec 27, 20243 filingsNov 7, 2025SEC

Stakes are as of each holder's latest filing. Holders whose last filing was in the old format (before December 18, 2024) have no stake on record and are not listed, and after an acquisition or delisting holders usually stop filing.

13D and 13G filings

12 Schedule 13D and 13G filings on Phio Pharmaceuticals Corp., newest first, including old-format filings without a stake.

Schedule 13D and 13G filings on PHIO
Filed (ET)FilerFormStakeChangeEvent dateFiling
Dec 11, 20254:30 PM ETOrca Capital AG13G/A4.90%538.7K shares−1.60 ppfrom 6.50%Below 5%Dec 8, 2025SEC
Nov 24, 20254:05 PM ETOrca Capital AG13G/A6.50%700.4K shares+1.60 ppfrom 4.90%Nov 20, 2025SEC
Nov 12, 20256:10 AM ETOrca Capital AG13G/A4.90%409.3K shares−4.90 ppfrom 9.80%Below 5%Nov 7, 2025SEC
Nov 10, 20256:36 PM ETCVI Investments, Inc.and 1 other13G9.90%733.3K shares+5.00 ppfrom 4.90%Nov 3, 2025SEC
Nov 7, 20255:27 PM ETIntracoastal Capital, LLCand 2 others13G/A7.00%430.0K shares−2.99 ppfrom 9.99%Sep 30, 2025SEC
Nov 6, 20255:00 PM ETOrca Capital AG13G/A9.80%800.0K shares+4.90 ppfrom 4.90%Nov 3, 2025SEC
Aug 7, 20254:05 PM ETOrca Capital AG13G/A4.90%280.6K shares−5.00 ppfrom 9.90%Below 5%Aug 4, 2025SEC
Feb 7, 20254:09 PM ETCVI Investments, Inc.and 1 other13G/A4.90%91.0K shares−2.40 ppfrom 7.30%Below 5%Dec 31, 2024SEC
Jan 23, 20253:45 PM ETOrca Capital AG13G9.90%515.0K sharesNewDec 19, 2024SEC
Jan 17, 20254:44 PM ETIntracoastal Capital, LLCand 2 others13G9.99%530.2K shares+5.00 ppfrom 4.99%Jan 13, 2025SEC
Dec 27, 20245:05 PM ETIntracoastal Capital, LLCand 2 others13G4.99%91.0K sharesNewBelow 5%Dec 19, 2024SEC
Dec 26, 20242:19 PM ETCVI Investments, Inc.and 1 other13G7.30%109.3K sharesNewDec 19, 2024SEC

Form 144: proposed insider sales

Notices from officers, directors and other affiliates planning to sell Phio Pharmaceuticals Corp. shares.

No Form 144 notices for Phio Pharmaceuticals Corp. are on file.